Rebel Vivienne I, Kung Andrew L, Tanner Elizabeth A, Yang Hong, Bronson Roderick T, Livingston David M
Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14789-94. doi: 10.1073/pnas.232568499. Epub 2002 Oct 23.
Hematopoietic stem cells (HSC) are tightly regulated through, as yet, undefined mechanisms that balance self-renewal and differentiation. We have identified a role for the transcriptional coactivators CREB-binding protein (CBP) and p300 in such HSC fate decisions. A full dose of CBP, but not p300, is crucial for HSC self-renewal. Conversely, p300, but not CBP, is essential for proper hematopoietic differentiation. Furthermore, in chimeric mice, hematologic malignancies emerged from both CBP(-/-) and p300(-/-) cell populations. Thus, CBP and p300 play essential but distinct roles in maintaining normal hematopoiesis, and, in mice, both are required for preventing hematologic tumorigenesis.
造血干细胞(HSC)通过尚未明确的机制受到严格调控,这些机制平衡自我更新和分化。我们已经确定转录共激活因子CREB结合蛋白(CBP)和p300在这种造血干细胞命运决定中发挥作用。全剂量的CBP对造血干细胞自我更新至关重要,而p300则不然。相反,p300对正常造血分化至关重要,而CBP则不然。此外,在嵌合小鼠中,血液系统恶性肿瘤源自CBP(-/-)和p300(-/-)细胞群体。因此,CBP和p300在维持正常造血过程中发挥着重要但不同的作用,并且在小鼠中,两者都是预防血液系统肿瘤发生所必需的。